Endogenex is a clinical-stage medical technology company developing a novel, minimally invasive endoscopic procedure for people with type 2 diabetes. Its ReCET™ system uses controlled pulsed electric fields applied to the duodenum to reset metabolic signaling and help the body better control blood glucose levels, aiming to go beyond current pharmacologic treatments and slow disease progression.